Arman is a PharmD investor combining operator execution with a Venture Partner background. He has co-founded and scaled ventures, bringing EMA insight, including experience with the orphan drug designation process to rigorous diligence. Having lived and worked on three continents, he leverages a global network to back bold, category-defining founders across healthcare and beyond, offering more than capital through hands-on portfolio support. He opens hard-to-reach doors through long-term relationships and disciplined execution — turning ‘not yet’ into access.

Thomas combines deep scientific expertise with strong business acumen, bringing over 15 years of experience building and leading biotech ventures. He has founded and scaled multiple companies from concept to clinical stage, securing significant funding and partnerships along the way. His venture partner experience and advisory roles across Kohde Pharma, Encelta, and Gordion Bioscience make him a trusted partner for founders tackling complex, science-driven challenges.

Armin is a Founding Partner at Mehr and a PharmD investor-operator with global perspective and clinical depth. As a former Collaborating Expert in Pharmacovigilance at the European Medicines Agency, he brings unique insight into the post-approval and real-world use of medicines. With a rigorously detail-oriented approach to due diligence and evaluation, Armin backs world-class founders addressing unmet medical needs at the intersection of science, technology, and healthcare innovation.